CohBar Expands Board with Biotech Veteran Misha Petkevich
MENLO PARK, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria […]
PyroGenesis Announces Closing of Small Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, Oct. 23, 2019 (GLOBE NEWSWIRE) […]
Alimera Sciences to Report Third Quarter 2019 Financial Results on Tuesday, October 29, 2019 and Provide Corporate Update
ATLANTA, Oct. 23, 2019 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development […]
Yield10 Bioscience Signs Research Agreement with J. R. Simplot to Evaluate New Traits to Produce High Yielding, Sustainable Potato Crop
WOBURN, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) today announced that it has signed a research […]
IMAC Holdings to Present on October 29th at the 5th Annual Dawson James Small Cap Growth Conference
BRENTWOOD, Tenn, Oct. 23, 2019 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq:IMAC), a provider of innovative medical advancements and care […]
Atossa Genetics to Present on October 29th at the 5th Annual Dawson James Small Cap Growth Conference
SEATTLE, Oct. 23, 2019 (GLOBE NEWSWIRE) — Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery […]
Ocugen Appoints Jessica Crespo, CPA, as Controller
MALVERN, Pa., Oct. 23, 2019 (GLOBE NEWSWIRE) — Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, […]
B.O.S. to Release Financial Results for the Third Quarter of 2019 on Tuesday, November 26, 2019
RISHON LEZION, Israel, Oct. 23, 2019 (GLOBE NEWSWIRE) — B.O.S. Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), […]
BBSI Appoints Diane L. Dewbrey to its Board of Directors
VANCOUVER, Wash., Oct. 23, 2019 (GLOBE NEWSWIRE) — The board of directors of Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), […]
Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
Results Presented in Late-Breaking Abstract as an Oral PresentationPresentation Will Also be Published in the Highlights from CHEST Special EditionWARREN, […]
